Literature DB >> 10053095

Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.

K Fukuda1, M Mori, M Uchiyama, K Iwai, T Iwasaka, H Sugimori, F Yamasaki.   

Abstract

OBJECTIVE: The aim of this study was to assess the significance of malignant or suspicious cervical cytology in preoperative identification of poor prognostic factors in endometrial carcinoma and to determine whether preoperative abnormal cervical cytology is an independent prognostic factor for endometrial carcinoma.
METHODS: We evaluated the correlation between preoperative cervical cytology and postoperative clinicopathologic findings, sites of metastasis, and receptor status from 99 surgically staged patients with endometrial carcinoma.
RESULTS: Sixty-eight patients (68.7%) had normal cervical cytology, 1 (1.0%) had atypical cytology suspicious for malignancy, and 30 (30.3%) had malignant cytology on preoperative cervical cytology. Malignant and suspicious cervical smears were statistically correlated with surgical stage (P = 0.001), histopathology (P = 0.010), tumor grade (P = 0.012), depth of myometrial tumor invasion (P = 0.001), cervical involvement (P = 0. 01), lymph node metastases (P = 0.002), adnexal metastases (P = 0. 012), progesterone receptor (P = 0.007), and estrogen receptor (P = 0.031). No association was found between preoperative cervical cytology and patients' age or peritoneal cytology. Univariate analysis showed that cervical cytology was related to survival (P = 0.018). However, multivariate analysis of cervical cytology, stage, grade, and myometrial invasion showed that preoperative cervical cytology was not a significant prognosticator for survival.
CONCLUSION: Patients with endometrial carcinoma who have malignant or suspicious cytology detected by preoperative cervical cytology are at increased risk of having known poor prognostic factors. However, positive preoperative cervical cytology itself does not appear to be an independent prognostic factor and probably should not influence treatment decisions in endometrial cancer. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10053095     DOI: 10.1006/gyno.1998.5244

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

2.  Preoperative cervical cytology as a prognostic factor in endometrioid-type endometrial cancer: A single-center experience from Saudi Arabia.

Authors:  Ahmed Abu-Zaid; Mohannad Alsabban; Osama Alomar; Mohammed Abuzaid; Mohammed Z Jamjoom; Hany Salem; Ismail A Al-Badawi
Journal:  Avicenna J Med       Date:  2020-07-03

3.  Role of less commonly agreed risk factors on disease recurrence in endometrial cancer: a propensity scorematched comparison.

Authors:  Hülya Ayık Aydın; Gülgün Erdoğan; Hatice Elif Pestereli; Tayup Şimşek
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.